Announce Date | 07/15/2025 |
EPS Normalized Actual | $-0.67 (Beat by $0.46) |
EPS GAAP Actual | $-0.67 (Beat by $0.46) |
Revenue Actual | $0.000138827B |
Revenue Surprise | Beat by $0.138827M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Feb 2027 | -0.1 | -37 | -0.1 | -0.1 | 1 |
Dec 2026 | -0.16 | -23.13 | -0.16 | -0.16 | 0 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (May 2025) | -0.68 | -0.68 | 0.000138827B | -35.99% | 0.14M |
FQ2 2024 (May 2024) | -1.55 | -1.55 | 0.000188793B | 100% | 0.19M |
FQ3 2024 (Aug 2024) | -1.13 | -1.13 | 0.000154498B | 100% | 0.15M |
FQ4 2024 (Nov 2024) | -347.66 | -347.66 | 7.4635E-5B | 100% | 0.07M |
FQ3 2011 (Jul 2011) | -0.0044 | -0.0044 | 0B | NAN% | 0M |
FQ4 2011 (Oct 2011) | -0.003 | -0.003 | 0B | NAN% | 0M |
FQ1 2012 (Jan 2012) | -0.0053 | -0.0053 | 0B | NAN% | 0M |
FQ1 2014 (Mar 2014) | -2.47 | -2.47 | 0B | NAN% | 0M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2030 (Aug 2030) | 0.15 | -- | 0.15 | 0.15 | 1 |
FQ2 2030 (May 2030) | 0.03 | -- | 0.03 | 0.03 | 1 |
FQ1 2030 (Feb 2030) | -0.1 | -- | -0.1 | -0.1 | 1 |
FQ4 2029 (Nov 2029) | -0.21 | -- | -0.21 | -0.21 | 1 |
FQ3 2029 (Aug 2029) | -0.17 | -- | -0.17 | -0.17 | 1 |
FQ2 2029 (May 2029) | -0.35 | -- | -0.35 | -0.35 | 1 |
FQ1 2029 (Feb 2029) | -1.13 | -- | -1.13 | -1.13 | 1 |
FQ4 2028 (Nov 2028) | -1.8 | -- | -1.8 | -1.8 | 1 |
FQ3 2028 (Aug 2028) | -1.8 | -- | -1.8 | -1.8 | 1 |
FQ2 2028 (May 2028) | -3.6 | -- | -3.6 | -3.6 | 1 |
FQ1 2028 (Feb 2028) | -3.9 | -- | -3.9 | -3.9 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2030 (Aug 2030) | 0.01B | -- | 0.01B | 0.01B | 1 |
FQ2 2030 (May 2030) | 0B | -- | 0B | 0B | 1 |
FQ1 2030 (Feb 2030) | 0B | -- | 0B | 0B | 1 |
FQ4 2029 (Nov 2029) | 0B | -- | 0B | 0B | 1 |
FQ3 2029 (Aug 2029) | 0B | -- | 0B | 0B | 1 |
FQ2 2029 (May 2029) | 0B | -- | 0B | 0B | 1 |
FQ1 2029 (Feb 2029) | 0B | -- | 0B | 0B | 1 |
FQ4 2028 (Nov 2028) | 0B | -- | 0B | 0B | 1 |
FQ3 2028 (Aug 2028) | 0B | -- | 0B | 0B | 1 |
FQ2 2028 (May 2028) | 0B | -- | 0B | 0B | 1 |
FQ1 2028 (Feb 2028) | 0B | -- | 0B | 0B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
0
EPS # of Misses
8
EPS # of in-lines
0
Revenue # of Beats
4
Revenue # of Misses
0
Revenue # of in-lines
4
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (May 2025) | -0.68 | -0.68 | 100% | |
FQ2 2024 (May 2024) | -1.55 | -1.55 | 100% | |
FQ3 2024 (Aug 2024) | -1.13 | -1.13 | 100% | |
FQ4 2024 (Nov 2024) | -347.66 | -347.66 | 100% | |
FQ3 2011 (Jul 2011) | -0.0044 | -0.0044 | 100% | |
FQ4 2011 (Oct 2011) | -0.003 | -0.003 | 100% | |
FQ1 2012 (Jan 2012) | -0.0053 | -0.0053 | 100% | |
FQ1 2014 (Mar 2014) | -2.47 | -2.47 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (May 2025) | $0B | $0B | $0.14M | 100% |
FQ2 2024 (May 2024) | $0B | $0B | $0.19M | 100% |
FQ3 2024 (Aug 2024) | $0B | $0B | $0.15M | 100% |
FQ4 2024 (Nov 2024) | $0B | $0B | $0.07M | 100% |
FQ3 2011 (Jul 2011) | $0B | $0B | $0M | NAN% |
FQ4 2011 (Oct 2011) | $0B | $0B | $0M | NAN% |
FQ1 2012 (Jan 2012) | $0B | $0B | $0M | NAN% |
FQ1 2014 (Mar 2014) | $0B | $0B | $0M | NAN% |